A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse

Recruiting N/A Interventional Study
Cigarette Smoking Smoking Behaviors Treatment
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
544 (estimated)
Sponsor
Medical University of South Carolina · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This is a research study to find out if treatment decision making can be improved for smokers who find it difficult to quit with medications. Everyone who participates in this study will receive free product, either nicotine replacement therapies (patches and lozenges), varenicline, or a harm reduction product (e-cigarette) for a full 12 weeks. Most participants will receive some combination of th…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Smokers who want to quit Exclusion Criteria: * Non-smokers
Contacts

Tracy T Smith, PhD

8438725164

smithtra@musc.edu

CONTACT

Matthew J Carpenter, PhD

8438762436

carpente@musc.edu

CONTACT